SEP 22, 2019 2:37 PM PDT

Genital Herpes Vaccine Works in Rodents

WRITTEN BY: Nouran Amin

A recent vaccine was developed by scientists at Perelman School of Medicine at the University of Pennsylvania that protects against genital herpes. The vaccine was administered on both mice and guinea pigs. Findings published in Science Immunology revealed "mostly sterilizing immunity" from the virus. This particular type of immunization is the strongest.

"We're extremely encouraged by the substantial immunizing effect our vaccine had in these animal models," said the study's principal investigator Harvey Friedman, MD, a professor of Infectious Diseases. "Based on these results, it is our hope that this vaccine could be translated into human studies to test both the safety and efficacy of our approach."

Using approaches in cutting edge cancer and immunotherapy studies, the developed vaccine was administered specifically to 64 mice that were then exposed to genital herpes. After 28 days, 63 of the mice displayed sterilizing immunity with no traces of the herpes infection and any evidence of the disease. The remaining mouse had a dormant infection without any priory genital herpes infection. The study was also applied to guinea pigs with similar results. Overall, no animal has developed genital lesions.

The vaccine, developed in collaboration between Penn Medicine and BioNTech, was filled with specific messenger RNA (mRNA) that creates proteins critical for strong immune responses. The vaccine stimulates three antibodies that block the herpes virus from entering cells and ensures that the virus doesn't "turn off" any innate immune system protective functions. Such an approach makes it unique than other methods for herpes vaccines because it often depends on inhibiting the entry of a virus.

Genital herpes, also known as the Herpes simplex virus type 2 or HSV-2, is the most common sexually-transmitted disease. Roughly 14 percent of Americans ages 14 to 59, and 11 percent of people in the same age range globally become infected. Symptoms include painful sores that spread to other areas of the body. The virus increases one's risk of getting HIV, and women who are infected and pregnant to threaten the fetus with infection particular during delivery.

"Along with physical symptoms, HSV-2 takes an emotional toll," said Friedman. "People worry over the transmission of the disease, and it can certainly have a negative effect on intimate relationships."

Learn more about genital herpes:

Source: Penn Medicine

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 03, 2021
Immunology
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
JUN 03, 2021
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper ...
JUN 24, 2021
Immunology
Should We Rethink COVID Vaccine Recipes?
JUN 24, 2021
Should We Rethink COVID Vaccine Recipes?
In a study reported in the journal Cell, immunologists provide evidence for an Achilles’ heel in current COVI ...
JUN 26, 2021
Cancer
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
JUN 26, 2021
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
Research shows that obese patients with cancers including ovarian and melanoma may respond better to a certain kind of i ...
JUL 08, 2021
Cancer
Activating p53 May Boost Efficacy of Cancer Immunotherapy
JUL 08, 2021
Activating p53 May Boost Efficacy of Cancer Immunotherapy
Pharmacological activation of the p53 protein in cancer cells leads to an anti-tumor immune response in lab tests. These ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
Loading Comments...